Hans Van Houte Nurix Therapeutics, Inc. (NRIX) insider trading activity

Hans Van Houte is Chief Financial Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 35,512 shares of NRIX, which is worth approximately $355,830. The most recent transaction as insider was on Oct 31, 2023, when has been sold 1,080 shares (Common Stock) at a price of $5.2 per share, resulting in proceeds of $5,616. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.5K

5.3% 3M change

30.37% 12M change

Total Value Held $355,830

Hans van Houte Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2023	SELL Open market or private sale	$5,616 $5.2 p/Share	1,080 Reduced 1.23%	86,377 Common Stock
Oct 30 2023	BUY Exercise of conversion of derivative security	-	4,886 Added 5.29%	87,457 Common Stock
Jul 31 2023	SELL Open market or private sale	$12,014 $9.65 p/Share	1,245 Reduced 1.49%	82,571 Common Stock
Jul 30 2023	BUY Exercise of conversion of derivative security	-	4,886 Added 5.51%	83,816 Common Stock
May 01 2023	SELL Open market or private sale	$7,123 $9.88 p/Share	721 Reduced 0.91%	78,930 Common Stock
Apr 30 2023	BUY Exercise of conversion of derivative security	-	2,886 Added 3.5%	79,651 Common Stock
Jan 30 2023	SELL Open market or private sale	$10,884 $11.78 p/Share	924 Reduced 1.19%	76,765 Common Stock
Jan 30 2023	BUY Exercise of conversion of derivative security	-	2,886 Added 3.58%	77,689 Common Stock
Oct 31 2022	SELL Open market or private sale	$9,518 $12.88 p/Share	739 Reduced 0.98%	74,803 Common Stock
Oct 30 2022	BUY Exercise of conversion of derivative security	-	2,886 Added 3.68%	75,542 Common Stock
Aug 01 2022	SELL Open market or private sale	$11,784 $15.67 p/Share	752 Reduced 1.02%	72,656 Common Stock
Jul 30 2022	BUY Exercise of conversion of derivative security	-	2,886 Added 3.78%	73,408 Common Stock
May 31 2022	BUY Exercise of conversion of derivative security	$57,400 $0.84 p/Share	68,333 Added 49.21%	70,522 Common Stock
May 02 2022	SELL Open market or private sale	$8,190 $11.75 p/Share	697 Reduced 24.15%	2,189 Common Stock
Apr 30 2022	BUY Exercise of conversion of derivative security	-	2,886 Added 50.0%	2,886 Common Stock
Feb 24 2021	SELL Open market or private sale	$1,413,218 $39.9 p/Share	35,419 Reduced 100.0%	0 Common Stock
Feb 24 2021	BUY Exercise of conversion of derivative security	$121,841 $3.44 p/Share	35,419 Added 50.0%	35,419 Common Stock
Feb 22 2021	SELL Open market or private sale	$212,827 $39.93 p/Share	5,330 Reduced 100.0%	0 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$5,437 $1.02 p/Share	5,330 Added 50.0%	5,330 Common Stock
Feb 18 2021	SELL Open market or private sale	$489,803 $36.06 p/Share	13,583 Reduced 100.0%	0 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$11,410 $0.84 p/Share	13,583 Added 50.0%	13,583 Common Stock

HvH

Hans Van Houte

Chief Financial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account